Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms

Sponsor
University of Illinois at Urbana-Champaign (Other)
Overall Status
Recruiting
CT.gov ID
NCT03011801
Collaborator
National Institute of Mental Health (NIMH) (NIH), University of Denver (Other)
240
2
2
63.9
120
1.9

Study Details

Study Description

Brief Summary

This study evaluates Interpersonal Therapy (IPT) in the treatment of depression among pregnant women with elevated depressive symptoms. Half of the women will be randomized to receive IPT, and the other half will get Treat As Usual, provided via behavioral health in the hospital.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Interpersonal Therapy
  • Behavioral: Enhanced usual care
N/A

Detailed Description

Exposure to maternal depressive symptoms is one of the most well established risk factors for the development of later child psychopathology. Accumulating evidence from naturalistic observational studies documents that fetal exposure to maternal depressive symptoms is associated with risk for later child mental health problems. Maternal depression is one of the most common prenatal complications with approximately 40% of women experiencing elevated levels of depressive symptoms. The majority of past research has been correlational, so potential causal conclusions have been limited. This project will break new ground by testing the hypothesis that manipulating maternal depressive symptoms will benefit infant outcomes. In this project, maternal depressive symptoms will be reduced using brief interpersonal therapy (IPT), a well-established and efficacious treatment, and testing whether this reduction leads to an improvement in the development of infant mechanisms associated with risk for later psychopathology. The investigators propose to assess 300 pregnant women who report elevated levels of depressive symptoms and their infants. Prior to the intervention, maternal measures of depressive symptoms will be collected. Then half of the women will be randomized to receive IPT and the other half will receive enhanced usual care (TAU). After completion of the intervention, maternal measures will be collected longitudinally through 14 months postpartum. Infants will be evaluated at birth and two other times. Infants will be assessed across four units of analysis (brain structure and function, physiology, behavior, and maternal-report).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Dec 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral: Interpersonal Therapy

Individual psychotherapy that includes an initial engagement session and a total of 8 sessions. IPT focuses on psychoeducation and interpersonal skill building to decrease interpersonal conflict and increase interpersonal support and competence.

Behavioral: Interpersonal Therapy
reducing conflict in relationships, increasing social support in relationships, improving communication, reducing depressive symptoms
Other Names:
  • IPT
  • Placebo Comparator: Enhanced Usual Care

    Maternity support services (MSS) is the usual standard of care for pregnant women. A multi-disciplinary team of obstetric care providers routinely screen women for possible depression diagnosis. If a woman screens positive, she is seen by a behavioral health specialist (BHS) for further assessment and to initiate treatment, if necessary. The goals of MSS include offering services to promote healthy pregnancies and positive birth and parenting outcomes, including integrating mental health and prenatal care. Women with elevated depressive symptoms are seen by BHS throughout the pregnancy and postpartum period and then bridged to mental health treatment. BHS provides eclectic-based care but does not provide IPT.

    Behavioral: Enhanced usual care
    Treatment as Usual, including eclectic and supportive therapy, as well as psychiatric medication
    Other Names:
  • Maternity Support Services (MSS)
  • Outcome Measures

    Primary Outcome Measures

    1. Presence of a Major Depressive Episode on SCID interview [12 months post pregnancy]

      Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation

    2. Symptom Checklist 20 (SCL20) [post intervention (approximately 2-3 months post baseline)]

      Self reported Depression Scores. higher scores=more depression

    3. Symptom Checklist 20 (SCL20) [6 months post intervention]

      Self reported Depression Scores. higher scores=more depression

    4. Symptom Checklist 20 (SCL20) [12 months post intervention]

      Self reported Depression Scores. higher scores=more depression

    Secondary Outcome Measures

    1. Edinburgh Postnatal Depression Scale (EPDS) [post intervention (approximately 2-3 months post baseline)]

      Self reported Depression Scores. higher scores=more depression

    2. Edinburgh Postnatal Depression Scale (EPDS) [6 months post intervention]

      Self reported Depression Scores. higher scores=more depression

    3. Edinburgh Postnatal Depression Scale (EPDS) [12 months post intervention]

      Self reported Depression Scores. higher scores=more depression

    4. Work and Social Adjustment Scale (WSAS) [post intervention (approximately 2-3 months post baseline)]

      general maternal functioning

    5. Work and Social Adjustment Scale (WSAS) [6 month post intervention]

      general maternal functioning

    6. Work and Social Adjustment Scale (WSAS) [12 month post intervention]

      general maternal functioning

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adult women (over 18 years of age)

    • A singleton intrauterine pregnancy

    • English speaking

    • Elevated depressive symptoms based on screening with the Edinburgh Postnatal Depression Scale (EPDS) with score > 9

    Exclusion Criteria:
    • Bipolar disorder and psychosis based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-NP)

    • Current psychotropic medication use or current CBT/IPT usage

    • An HPA axis or an endocrine disorder

    • Maternal substance use [assessed using maternal report and urine toxicology

    • Corticosteroid medication use during this pregnancy

    • Invitto fertilization

    • Presence of cervical or uterine abnormalities

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Denver Denver Colorado United States 80208
    2 University of Illinois Urbana Illinois United States 61801

    Sponsors and Collaborators

    • University of Illinois at Urbana-Champaign
    • National Institute of Mental Health (NIMH)
    • University of Denver

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Illinois at Urbana-Champaign
    ClinicalTrials.gov Identifier:
    NCT03011801
    Other Study ID Numbers:
    • MH109662
    First Posted:
    Jan 5, 2017
    Last Update Posted:
    Feb 15, 2021
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 15, 2021